First chikungunya vaccine approved for persons as young as 12 years old, addressing an unmet need for chikungunya prevention for younger ...
Bavarian Nordic (OTCPK:BVNRY) has received FDA approval for its vaccine Vimkunya for the prevention of chikungunya. The virus-like particle, or VLP, vaccine is approved for people aged 12 and older.
According to the Hospital Central del Instituto de Previsión Social (IPS), about 30% of its staff is on bed rest after being diagnosed with chikungunya. “We estimate that 30 % of our staff is ...
Colombo, February 4 (Daily Mirror) - Sri Lanka is experiencing a rise in Chikungunya cases, with the highest number of infections being reported across the country. Paediatrician at Lady Ridgeway ...
A definitive diagnosis of Chikungunya infection can be made only with the aid of laboratory support since clinically, symptoms resemble those of dengue fever. Laboratory diagnosis is therefore ...
15d
First chikungunya vaccine recommended by the CHMP for persons as young as 12 years old.The virus-like particle (VLP) single-dose chikungunya ...
En ambos casos, la región más afectada es América y, en concreto, el chikungunya se encuentra más extendido en Brasil, Paraguay y Colombia. En Europa continental, el riesgo de transmisión de ...
El Centro Europeo para la Prevención y el Control de Enfermedades (ECDC) ha dado a conocer los últimos datos referentes al panorama mundial del dengue y el Chikungunya. Ambas afecciones han registrado ...
Bavarian Nordic’s chikungunya vaccine Vimkunya is one step closer to being available in Europe after having secured an European Medicines Agency (EMA) recommendation for a marketing authorisation. If ...
a) Estadística descriptiva o deductiva: se basa en la recolección de datos y su clasificación, elaboración de tablas y gráficos que resumen esos datos; además, como la determinación de ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback